[1]
L. Sher, W. Soong, R. Prescilla, Z. Chen, and A. Bansal, “Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis and a History of Allergic Rhinitis: Subgroup Analysis From a Phase 3 Trial (LIBERTY AD ADOL)”, J of Skin, vol. 4, no. 5, p. s51, Sep. 2020.